School closures reduced social mixing of children during COVID-19 with implications for transmission risk and school reopening policies.
COVID-19
SARS-CoV-2
children social networks
contact rate
school closures and reopening
transmission model
Journal
Journal of the Royal Society, Interface
ISSN: 1742-5662
Titre abrégé: J R Soc Interface
Pays: England
ID NLM: 101217269
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
entrez:
14
4
2021
pubmed:
15
4
2021
medline:
22
6
2021
Statut:
ppublish
Résumé
School closures may reduce the size of social networks among children, potentially limiting infectious disease transmission. To estimate the impact of K-12 closures and reopening policies on children's social interactions and COVID-19 incidence in California's Bay Area, we collected data on children's social contacts and assessed implications for transmission using an individual-based model. Elementary and Hispanic children had more contacts during closures than high school and non-Hispanic children, respectively. We estimated that spring 2020 closures of elementary schools averted 2167 cases in the Bay Area (95% CI: -985, 5572), fewer than middle (5884; 95% CI: 1478, 11.550), high school (8650; 95% CI: 3054, 15 940) and workplace (15 813; 95% CI: 9963, 22 617) closures. Under assumptions of moderate community transmission, we estimated that reopening for a four-month semester without any precautions will increase symptomatic illness among high school teachers (an additional 40.7% expected to experience symptomatic infection, 95% CI: 1.9, 61.1), middle school teachers (37.2%, 95% CI: 4.6, 58.1) and elementary school teachers (4.1%, 95% CI: -1.7, 12.0). However, we found that reopening policies for elementary schools that combine universal masking with classroom cohorts could result in few within-school transmissions, while high schools may require masking plus a staggered hybrid schedule. Stronger community interventions (e.g. remote work, social distancing) decreased the risk of within-school transmission across all measures studied, with the influence of community transmission minimized as the effectiveness of the within-school measures increased.
Identifiants
pubmed: 33849340
doi: 10.1098/rsif.2020.0970
pmc: PMC8086933
doi:
Banques de données
figshare
['10.6084/m9.figshare.c.5365212']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
20200970Subventions
Organisme : NIAID NIH HHS
ID : R01 AI125842
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI148336
Pays : United States
Organisme : NICHD NIH HHS
ID : P2C HD073964
Pays : United States
Commentaires et corrections
Type : UpdateOf
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
N Engl J Med. 2020 Apr 30;382(18):e40
pubmed: 32227759
Science. 2020 Nov 6;370(6517):691-697
pubmed: 33154136
BMC Med. 2020 May 7;18(1):124
pubmed: 32375776
Infect Dis Model. 2020 Apr 21;5:293-308
pubmed: 32355904
Proc Biol Sci. 2016 Jul 13;283(1834):
pubmed: 27412286
Nat Commun. 2021 Feb 16;12(1):1073
pubmed: 33594076
PLoS Comput Biol. 2017 Sep 12;13(9):e1005697
pubmed: 28898249
J Infect Dis. 2021 Feb 13;223(3):362-369
pubmed: 33119738
BMJ. 2021 Mar 18;372:n628
pubmed: 33737413
Nat Hum Behav. 2020 Dec;4(12):1294-1302
pubmed: 33144713
Lancet Glob Health. 2020 May;8(5):e644
pubmed: 32222161
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):136-140
pubmed: 33507890
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
Travel Med Infect Dis. 2020 Jul - Aug;36:101751
pubmed: 32473312
Lancet Child Adolesc Health. 2020 Nov;4(11):817-827
pubmed: 32758453
PLoS Comput Biol. 2012;8(3):e1002425
pubmed: 22412366
Nat Commun. 2021 Feb 9;12(1):893
pubmed: 33563992
Lancet Infect Dis. 2021 Mar;21(3):344-353
pubmed: 33306981
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):
pubmed: 33574041
Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13174-13181
pubmed: 31209042
JAMA Intern Med. 2021 Mar 1;181(3):381-383
pubmed: 33136116
BMJ. 2020 May 12;369:m1808
pubmed: 32398230
Prev Med Rep. 2016 Dec 06;5:86-91
pubmed: 27981021
J R Soc Interface. 2010 Jun 6;7(47):873-85
pubmed: 19892718
Science. 2020 Jun 26;368(6498):1481-1486
pubmed: 32350060
N Engl J Med. 2020 Sep 3;383(10):981-985
pubmed: 32726550
JAMA. 2021 Mar 2;325(9):823-824
pubmed: 33497433
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
Clin Infect Dis. 2021 May 4;72(9):1493-1496
pubmed: 32584967
PLoS One. 2008 Jul 09;3(7):e2618
pubmed: 18612429
Lancet Public Health. 2020 Aug;5(8):e452-e459
pubmed: 32682487
J Pediatr. 2020 Aug;223:188-193
pubmed: 32439312
Lancet Infect Dis. 2020 May;20(5):553-558
pubmed: 32171059
Nature. 2021 Jan;589(7843):503
pubmed: 33479532
MMWR Morb Mortal Wkly Rep. 2020 Aug 07;69(31):1023-1025
pubmed: 32759921
Emerg Infect Dis. 2020 Oct;26(10):2465-2468
pubmed: 32673193
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1319-1323
pubmed: 32941418
Lancet Public Health. 2020 May;5(5):e243-e244
pubmed: 32275858
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Lancet Infect Dis. 2020 Oct;20(10):1141-1150
pubmed: 32562601
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2825-30
pubmed: 21282645
PLoS Comput Biol. 2021 Feb 11;17(2):e1008559
pubmed: 33571188
Pediatrics. 2021 Jan 8;:
pubmed: 33419869